Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum.
EClinicalMedicine
; 46: 101344, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35295900
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
EClinicalMedicine
Year:
2022
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom